FOSTER CITY, Calif. - Gilead Sciences, Inc. (NASDAQ:GILD), a biopharmaceutical firm with a market capitalization of $119.87 billion, announced today a 2.6% increase in its quarterly cash dividend.

Key Insights Using the Dividend Discount Model, PRL Global fair value estimate is AU$1.08 PRL Global's AU$1.24 ...

An upside to its dividend payout ratio, better credit costs, potential loan growth upgrade and stable cost of funds are the ...

Boston Pizza offers monthly dividends and buybacks by generating revenue from royalties based on sales from its franchised ...

As a result, Healthpeak’s life science and medical office portfolios are now prominently featured in the company's portfolio as the proceeds from the senior housing sales were reinvested into these ...

Money market yield measures the annualized return on short-term, low-risk investments like Treasury bills and commercial ...

Vornado Realty Trust (NYSE:VNO) is a real estate investment trust that has a collection of premier assets and a focused ...

Discover how BNDX, a USD-hedged European bond ETF, offers a 3.06% yield amid diverging monetary policies and economic trends ...

If you need to generate income from your investments, selecting securities or funds based on their current interest or ...

The stock looks like a decent value, but it could be a bargain if management can execute. Its dividend checks all the boxes ...

Unfortunately, that's been the case for longer term Celebrus Technologies plc (LON:CLBS) shareholders, since the share price is down 24% in the last three years, falling well short of the market ...

Granite Point Mortgage Trust (NYSE:GPMT – Get Free Report) is expected to be posting its quarterly earnings results after the ...